Announcing Spiderwort's CelluBridge Clinical Advisory Board 
Pioneers in Neuroscience Join Forces with Spiderwort to Revolutionize Spinal Cord Injury Treatment Ottawa, Canada — October 9, 2024 — Spiderwort Inc., the biotechnology company innovating in cellulose-based tissue engineering, today announced its Clinical Advisory Board for CelluBridge, the firm’s […]
Spiderwort Co-Founders at Techcracker 2024 in Japan
Spiderwort collaborates with entrepreneurs and innovators in life sciences, March 2024. Spiderwort’s co-founders, Dr. Charles M. Cuerrier and Dr. Andrew Pelling travelled to Japan for the Techcracker 2024 and Techcracker Labs events, hosted by Horizons Ventures. Celebrating its 10th anniversary […]
Spiderwort at IMCAS World Congress 2024
Celebrating Innovation in Medical Aesthetics Ottawa, Canada — January 25, 2024 — Spiderwort, the biotech company transforming regenerative medicine, will attend the IMCAS World Congress next week in Paris, France from February 1-3, 2024. This year marks the 25th anniversary […]
Spiderwort’s 2023 Year in Review: Advancing Innovation in Regenerative Medicine
As 2023 comes to a close, we look back at the progress and advancement we’ve made to push the boundaries of regenerative medicine through our continued investment in cellulose-based biomaterial research and development. Both of our product lines — CelluBridge and […]
Introducing Spiderwort's CelluJuve® Clinical Advisory Board
Top Aesthetic Medical Professionals Team Up with Spiderwort to Redefine Dermal Filler Innovations Ottawa, Canada — December, 5, 2023 — Spiderwort Inc., the biotechnology company innovating in plant-based tissue engineering, today announced its Clinical Advisory Board for CelluJuve®, the firm’s […]
Spiderwort Executive Joins Canada's Premier Biotech Leadership Development Program
Dr. Stephen Hanson, Spiderwort Business Development Director, Joins Elite Cohort Ottawa, Canada — November,28, 2023 — Spiderwort Inc., the biotech company innovating in cellulose-based tissue engineering, is proud to announce its Business Development Director, Dr. Stephen Hanson, has been selected […]
Spiderwort Selected to Join Elite CELS Valley Ready Program
Admission to Prestigious Program to Bolster Biotechnology Firm’s Global Reach in Life Sciences Ottawa, Canada — November, 22, 2023 — Spiderwort Inc., the biotechnology company innovating in cellulose-based tissue engineering, today announced its acceptance to the prestigious Canadian Entrepreneur in […]
Spiderwort Embarks on November European Tour
Forging Global Partnerships in Regenerative Medicine Ottawa, Canada — October, 27, 2023 — Spiderwort Inc, the biotech company leading in regenerative medicine, will embark on a regional European tour this upcoming November with a focus on building partnerships with researchers, […]
Spiderwort Accepted to Tech Accelerator, MaRS Health Science Portfolio
This important milestone follows Spiderwort’s graduation to Invest Ottawa’s “ScaleUp” venture development program Ottawa — June 6, 2023 — Spiderwort Inc., the biotech company innovating in cellulose-based tissue engineering, is proud to announce it has been accepted to the prestigious […]
Spiderwort Wins Prestigious Judge's Choice Award at Industry-Leading Octane Medical Aesthetics Tech Forum
This award follow’s Spiderwort’s inaugural presentation to the medical aesthetics industry in the U.S. market. Ottawa — February 7, 2023 — Spiderwort Inc., the biotech company innovating in cellulose-based tissue engineering, is proud to announce it has been selected as […]
Please contact us for press kit or media inquiries.
Contact Us